Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Julius Morrow, M.D., Ph.D.

Concepts (80)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with James Morrow's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that James Morrow has written about over time.
Bone Neoplasms, 1 publications between 2015 and 2015, average publication date December 2014. Genetic Association Studies, 1 publications between 2015 and 2015, average publication date December 2014. Epigenesis, Genetic, 2 publications between 2015 and 2017, average publication date January 2016. Neoplasm Metastasis, 2 publications between 2014 and 2018, average publication date June 2016. RNA, Messenger, 1 publications between 2016 and 2016, average publication date June 2016. TOR Serine-Threonine Kinases, 1 publications between 2016 and 2016, average publication date June 2016. Cell Line, Tumor, 7 publications between 2014 and 2019, average publication date November 2016. Gene Expression Regulation, Neoplastic, 5 publications between 2014 and 2018, average publication date January 2017. Xenograft Model Antitumor Assays, 4 publications between 2016 and 2017, average publication date April 2017. Osteosarcoma, 4 publications between 2015 and 2019, average publication date April 2017. Lung Neoplasms, 3 publications between 2014 and 2019, average publication date June 2017. Transcriptional Elongation Factors, 1 publications between 2017 and 2017, average publication date July 2017. Transcription Factor AP-1, 2 publications between 2017 and 2018, average publication date July 2017. Enhancer Elements, Genetic, 4 publications between 2017 and 2018, average publication date August 2017. Molecular Targeted Therapy, 2 publications between 2017 and 2017, average publication date September 2017. Thromboplastin, 1 publications between 2018 and 2018, average publication date January 2018. Protein Kinase Inhibitors, 2 publications between 2016 and 2019, average publication date February 2018. Cyclin-Dependent Kinases, 1 publications between 2019 and 2019, average publication date September 2019. Myofibromatosis, 1 publications between 2023 and 2023, average publication date February 2023.

To see the data from this visualization as text, click here.
Morrow's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (80)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.